Timor-Leste vs Viet Nam: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Timor-Leste
1.0%
in 2024
Viet Nam
0.9%
in 2024
Timor-Leste rank
3rd
Viet Nam rank
4th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Timor-Leste
- Viet Nam
How they compare
Timor-Leste currently reports 1.0% against 0.9% in Viet Nam, a difference of 0.1%.
That makes Timor-Leste's figure about 1.1 times Viet Nam's.
Across all 10 years both countries report, Timor-Leste has been ahead every year.
Timor-Leste ranks 3rd and Viet Nam ranks 4th of 15 countries.
Timor-Leste has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Timor-Leste | Viet Nam | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.5% | 1.2% | 1.3% | Timor-Leste |
| 2020s | 1.3% | 1.0% | 0.3% | Timor-Leste |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Timor-Leste or Viet Nam?
- Timor-Leste, at 1.0% against 0.9% in Viet Nam as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Timor-Leste and Viet Nam?
- 0.1%, with Timor-Leste ahead.
- How many years of comparable data are there for Timor-Leste and Viet Nam?
- 10 years are reported by both, from 2015 to 2024.
- How do Timor-Leste and Viet Nam rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Timor-Leste ranks 3rd and Viet Nam ranks 4th of 15 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.